CBBYX
Price
$6.11
Change
+$0.05 (+0.83%)
Updated
Apr 24 closing price
Net Assets
1.75B
VIVAX
Price
$64.41
Change
+$0.63 (+0.99%)
Updated
Apr 24 closing price
Net Assets
190.51B
Ad is loading...

CBBYX vs VIVAX

Header iconCBBYX vs VIVAX Comparison
Open Charts CBBYX vs VIVAXBanner chart's image
AB Relative Value Advisor
Price$6.11
Change+$0.05 (+0.83%)
VolumeN/A
Net Assets1.75B
Vanguard Value Index I
Price$64.41
Change+$0.63 (+0.99%)
VolumeN/A
Net Assets190.51B
CBBYX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CBBYX vs. VIVAX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBBYX is a Buy and VIVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 191B vs. CBBYX (1.75B). VIVAX pays higher dividends than CBBYX: VIVAX (2.14) vs CBBYX (1.19). CBBYX was incepted earlier than VIVAX: CBBYX (29 years) vs VIVAX (33 years). CBBYX (0.70) is less costly to investors than VIVAX (0.17). CBBYX is a more actively managed with annual turnover of: 58.00 vs. VIVAX (10.00). CBBYX has a lower initial minimum investment than VIVAX: CBBYX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 3.39 vs. CBBYX (-7.11). VIVAX return over 5 years is better than : 69.89 vs. CBBYX (42.05).
CBBYXVIVAXCBBYX / VIVAX
Total Expense Ratio0.650.17382%
Annual Report Gross Expense Ratio0.700.17412%
Fund Existence29 years33 years-
Gain YTD-3.503-3.426102%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.75B191B1%
Annual Yield % from dividends1.192.1456%
Returns for 1 year-7.113.39-210%
Returns for 3 years-3.4212.71-27%
Returns for 5 years42.0569.8960%
Returns for 10 years18.5192.4520%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOUN9.380.63
+7.20%
SoundHound AI
VNT31.291.06
+3.51%
Vontier Corp
GS545.3716.06
+3.03%
Goldman Sachs Group
ZH3.910.03
+0.77%
Zhihu
ACRV1.99-0.01
-0.50%
Acrivon Therapeutics